Lilly Asia Ventures

礼来亚洲基金

Lilly Asia Ventures

Venture Capital

Lilly Asia Ventures (LAV) was established in 2008 as the venture capital arm of Eli Lilly and became an independent investment management company in 2011. It has since grown into a leading life sciences and healthcare venture capital firm.

140 recorded investments

Source: ChinaBulls — chinabulls.com

Last updated 2026-10-19